These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1398 related articles for article (PubMed ID: 8545743)
1. Morphological characterisation of the cell-growth inhibitory activity of rooperol and pharmacokinetic aspects of hypoxoside as an oral prodrug for cancer therapy. Albrecht CF; Theron EJ; Kruger PB S Afr Med J; 1995 Sep; 85(9):853-60. PubMed ID: 8545743 [TBL] [Abstract][Full Text] [Related]
2. beta-Glucosidase activity in fetal bovine serum renders the plant glucoside, hypoxoside, cytotoxic toward B16-F10-BL-6 mouse melanoma cells. Theron EJ; Albrecht CF; Kruger PB; Jenkins K; van der Merwe MJ In Vitro Cell Dev Biol Anim; 1994 Feb; 30A(2):115-9. PubMed ID: 8012653 [TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetic behaviour of hypoxoside taken orally by patients with lung cancer in a phase I trial. Albrecht CF; Kruger PB; Smit BJ; Freestone M; Gouws L; Miller R; van Jaarsveld PP S Afr Med J; 1995 Sep; 85(9):861-5. PubMed ID: 8545744 [TBL] [Abstract][Full Text] [Related]
4. Studies on hypoxoside and rooperol analogues from Hypoxis rooperi and Hypoxis latifolia and their biotransformation in man by using high-performance liquid chromatography with in-line sorption enrichment and diode-array detection. Kruger PB; Albrecht CF; Liebenberg RW; van Jaarsveld PP J Chromatogr B Biomed Appl; 1994 Dec; 662(1):71-8. PubMed ID: 7894695 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic behaviour and cardiovascular effects of intravenously administered hypoxoside and rooperol. Coetzee JF; Kruger PB; Albrecht CF; Jahed N; van Jaarsveld PP Arzneimittelforschung; 1996 Oct; 46(10):997-1000. PubMed ID: 8931895 [TBL] [Abstract][Full Text] [Related]
6. A phase I trial of hypoxoside as an oral prodrug for cancer therapy--absence of toxicity. Smit BJ; Albrecht CF; Liebenberg RW; Kruger PB; Freestone M; Gouws L; Theron E; Bouic PJ; Etsebeth S; van Jaarsveld PP S Afr Med J; 1995 Sep; 85(9):865-70. PubMed ID: 8545745 [TBL] [Abstract][Full Text] [Related]
7. Selective ROS-dependent p53-associated anticancer effects of the hypoxoside derivative rooperol on human teratocarcinomal cancer stem-like cells. Ali Azouaou S; Emhemmed F; Idris-Khodja N; Lobstein A; Schini-Kerth V; Muller CD; Fuhrmann G Invest New Drugs; 2015 Feb; 33(1):64-74. PubMed ID: 25404486 [TBL] [Abstract][Full Text] [Related]
8. Rooperol as an antioxidant and its role in the innate immune system: an in vitro study. Boukes GJ; van de Venter M J Ethnopharmacol; 2012 Dec; 144(3):692-9. PubMed ID: 23085395 [TBL] [Abstract][Full Text] [Related]
9. Investigation of the antioxidant activity of African potato (Hypoxis hemerocallidea). Nair VD; Dairam A; Agbonon A; Arnason JT; Foster BC; Kanfer I J Agric Food Chem; 2007 Mar; 55(5):1707-11. PubMed ID: 17295502 [TBL] [Abstract][Full Text] [Related]
10. Cell survival or apoptosis: rooperol's role as anticancer agent. Boukes GJ; Daniels BB; Albrecht CF; van de Venter M Oncol Res; 2010; 18(8):365-76. PubMed ID: 20441051 [TBL] [Abstract][Full Text] [Related]
11. Interaction of the di-catechols rooperol and nordihydroguaiaretic acid with oxidative systems in the human blood. A structure-activity relationship. Van der Merwe MJ; Jenkins K; Theron E; van der Walt BJ Biochem Pharmacol; 1993 Jan; 45(2):303-11. PubMed ID: 8382058 [TBL] [Abstract][Full Text] [Related]
12. In vivo antimetastatic action of ginseng protopanaxadiol saponins is based on their intestinal bacterial metabolites after oral administration. Wakabayashi C; Hasegawa H; Murata J; Saiki I Oncol Res; 1997; 9(8):411-7. PubMed ID: 9436194 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of B16-BL6 melanoma lung colonies by semisynthetic sulfaminoheparosan sulfates from E. coli K5 polysaccharide. Poggi A; Rossi C; Casella N; Bruno C; Sturiale L; Dossi C; Naggi A Semin Thromb Hemost; 2002 Aug; 28(4):383-92. PubMed ID: 12244486 [TBL] [Abstract][Full Text] [Related]
15. Metabolism and excretion of the novel bioreductive prodrug PR-104 in mice, rats, dogs, and humans. Gu Y; Atwell GJ; Wilson WR Drug Metab Dispos; 2010 Mar; 38(3):498-508. PubMed ID: 20019245 [TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity and antitumor activity of carzelesin, a prodrug cyclopropylpyrroloindole analogue. Li LH; DeKoning TF; Kelly RC; Krueger WC; McGovren JP; Padbury GE; Petzold GL; Wallace TL; Ouding RJ; Prairie MD Cancer Res; 1992 Sep; 52(18):4904-13. PubMed ID: 1516047 [TBL] [Abstract][Full Text] [Related]
17. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice. Beland FA Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702 [TBL] [Abstract][Full Text] [Related]
18. Cytokine production in human and rat macrophages and dicatechol rooperol and esters. Guzdek A; Nizankowska E; Allison AC; Kruger PB; Koj A Biochem Pharmacol; 1996 Oct; 52(7):991-8. PubMed ID: 8831717 [TBL] [Abstract][Full Text] [Related]
19. Effect of rooperol on collagen synthesis and cell growth. Dietzsch E; Albrecht CF; Parker MI IUBMB Life; 1999 Sep; 48(3):321-5. PubMed ID: 10690646 [TBL] [Abstract][Full Text] [Related]
20. Construction, expression, and activities of L49-sFv-beta-lactamase, a single-chain antibody fusion protein for anticancer prodrug activation. Siemers NO; Kerr DE; Yarnold S; Stebbins MR; Vrudhula VM; Hellström I; Hellström KE; Senter PD Bioconjug Chem; 1997; 8(4):510-9. PubMed ID: 9258449 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]